Around PATH, the idea that partnering with the private sector can lead to global health and development solutions has been part of our work for decades. For an example, look no farther than the Uniject™ injection system, developed by PATH, licensed to manufacturer BD, and mentioned in a story in The Guardian on the potential of public-private partnerships. It’s one of the stories that caught our attention this week.
NGOs partnering with business to accelerate shared value
The Guardian, October 17, 2012
It used to be that a typical meeting between a business and nongovernmental organisation (NGO) resulted in one of two outcomes: confrontation or a donation. Think Greenpeace versus McDonalds or corporate philanthropic funding to the United Way and Habitat for Humanity.
But times are changing.
Riding the wave of public-private partnerships and the idea of shared value, NGOs are rethinking their relationship with the private sector to better meet their social missions. Read the article.
How cell phones helped researchers track malaria in Kenya
NPR, October 11, 2012
Cellphones are popping up all over in health care these days. They’re monitoring our blood sugar, tracking the flu season, and even mapping the junk food we eat at night.
But compared to a study just published in Science, these crowdsourcing tools look like small potatoes.
Researchers at Harvard School of Public Health tracked the texts and calls from nearly 15 million cellphones in Kenya for an entire year and then used the data to make a map for how malaria spreads around the Texas-sized country. The results were unexpected. Read the article.
HPV shot doesn’t encourage sexual activity in girls: study
U.S. News & World Report, October 15, 2012
Young girls who receive a vaccine to protect against the virus that causes cervical cancer do not become sexually promiscuous after the shot, new research finds.
Two versions of a vaccination against the sexually transmitted human papillomavirus (HPV), which causes cervical and some other forms of cancer, are available and recommended to all girls aged 11 to 12.
But less than half of girls eligible for the shot have received it, apparently due in part to concerns that it might encourage sexual activity. Read the article.